Evaluation of a pilot program for managing chronic diseases in Hong Kong
An Evaluation of the Effectiveness and Cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a Commissioned Study
This study is testing a new program to see if it can help people aged 45 and older in Hong Kong manage their high blood pressure and diabetes better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3772 (estimated) |
| Ages | 45 Years and up |
| Sex | All |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06310148 on ClinicalTrials.gov |
What this trial studies
The Chronic Disease Co-Care (CDCC) Pilot Scheme aims to enhance the early screening and management of hypertension and diabetes in Hong Kong. This 12-month cohort study will assess the quality of care, feasibility, acceptability, effectiveness, and cost-effectiveness of the program. Participants will include individuals aged 45 and older who are registered with District Health Centres, and their health outcomes will be compared to a control group of non-participants. Data will be collected through questionnaires and surveys to evaluate participant experiences and healthcare provider adherence to care standards.
Who should consider this trial
Good fit: Ideal candidates for this study are Hong Kong residents aged 45 and older who are registered members of District Health Centres and do not have a known history of diabetes or hypertension.
Not a fit: Patients with a known history of diabetes or hypertension will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the management and outcomes of chronic diseases like hypertension and diabetes for patients in Hong Kong.
How similar studies have performed: Other studies have shown success with similar chronic disease management approaches, indicating potential for positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria of interventional group: * Hong Kong residents * Aged ≥45 years * Registered as a member of DHC/DHC Express * Provided informed consent on sharing their data in the electronic Health Record Sharing System * Provided consent to join the CDCC Pilot Scheme Terms and Conditions. Exclusion Criteria of interventional group: * With known history of DM or HT Inclusion Criteria of comparison group: * Hong Kong residents * Aged ≥45 years * Provided informed consent for the study. Exclusion Criteria of comparison group: * Without known history of DM or HT
Where this trial is running
Hong Kong
- Jockey Club Building for Interdisciplinary Research 5 Sassoon Road, Pok Fu Lam, HONG KONG — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Study coordinator: Eric Yuk Fai Wan
- Email: yfwan@hku.hk
- Phone: 852 2831 5057
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.